ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994

Community Cancer Control Program Survives Schmidt Criticism; NCAB Votes To Continue

October 17, 1975

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988